Eric Leire is an accomplished CEO and former research associate with multiple leadership roles in biotech and pharma organizations. Eric holds an MBA from the Kellogg School of Management and an MD in medicine from the Université Joseph Fourier. He also studied at HEC School of Management.

Over the years, Eric has worked with various organizations in different capacities, including CEO & President at Enochian Biosciences, CEO at DKTI, and Executive Chairman at IMMUNETHEP. Eric's extensive experience has helped him thrive in critical roles such as Partner at NEEI BioMed and Partner at BioFund.

Eric has also been an active member of the board of directors in several leading companies: Non-Executive Director at BSIM Therapeutics, Non-Executive Director at InhaTarget Therapeutics, and Non-Executive Director at Novicol International Holding Inc.

Currently, Eric Leire is the CEO of GenFlow Biosciences, a leading biotech company that specializes in drug discovery and development. Eric's diverse expertise in business, finance, and science has made him an integral part of many influential biotech and pharma organizations.